Piramal Pharma Ltd

NSE: PPLPHARMA · BSE: 543635 · Pharmaceuticals & Biotechnology · 32 announcements

Share price: ₹206.59
Market cap: ₹27,504 Cr
Revenue (annual): ₹8,869 Cr
Net profit (annual): ₹-325.9 Cr
P/E (TTM): -87.7×Sector 49.7×
Promoter holding: 34.80%-0.06% QoQ
FII holding: 12.51%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Business Update 4 Other Announcement 3 Share Pledge 2 Merger & Restructuring 2 Annual General Meeting 2 Results Update 1 Regulatory Approval 1 Financial Results 1 Employee Stock Options 1 Earnings Call 1 Board Meeting Date 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

30 Jul 2026 20:12 IST BSE

Annual General Meeting

Piramal Pharma Annual General Meeting

Piramal Pharma Limited concluded its 6th Annual General Meeting, where shareholders approved all resolutions, including director re-appointments, auditor remuneration, and NCD issuance authority.

Read the filing ↗

3 Jul 2026 15:15 IST BSE

Annual General Meeting

Piramal Pharma Annual General Meeting

Piramal Pharma Ltd announces its 6th AGM on 30 July 2026 and releases the FY 2025‑26 Annual Report. Shareholders may view it via QR code or the website.

Read the filing ↗